Candesartan Cilexetil; Hydrochlorothiazide Patent Expiration
Candesartan Cilexetil; Hydrochlorothiazide is Used for treating high blood pressure. It was first introduced by Ani Pharmaceuticals Inc
Candesartan Cilexetil; Hydrochlorothiazide Patents
Given below is the list of patents protecting Candesartan Cilexetil; Hydrochlorothiazide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Atacand Hct | US5721263 | Pharmaceutical composition for angiotensin II-mediated diseases |
Feb 24, 2015
(Expired) | Ani Pharms |
| Atacand Hct | US5958961 | Pharmaceutical composition for angiotensin II-mediated diseases |
Jun 06, 2014
(Expired) | Ani Pharms |
| Atacand Hct |
US5534534 (Pediatric) | Pharmaceutical compositions for oral use and method of preparing them |
Jan 09, 2014
(Expired) | Ani Pharms |
| Atacand Hct | US5534534 | Pharmaceutical compositions for oral use and method of preparing them |
Jul 09, 2013
(Expired) | Ani Pharms |
| Atacand Hct |
US5196444 (Pediatric) | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
Dec 04, 2012
(Expired) | Ani Pharms |
Candesartan Cilexetil; Hydrochlorothiazide's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List